Alaunos Therapeutics, Inc. (TCRT) Tops Q4 EPS by 1c

Alaunos Therapeutics, Inc. (NASDAQ: TCRT) reported Q4 EPS of ($0.04), $0.01 better than the analyst estimate of ($0.05).

For earnings history and earnings-related data on Alaunos Therapeutics, Inc. (TCRT) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery